One Suspected Case of Vision Impairment Following GLP-1 Administration in Korea
4 Articles
4 Articles
A suspected case of vision impairment following the administration of obesity drugs has emerged in Korea. The issue of obesity drug safety was raised during the parliamentary audit of the Ministry of Food and Drug Safety and other agencies held on the 13th by the National Assembly Health and Welfare Committee. On that day, Rep. Baek Sun-hee of the Cho Kuk Innovation Party asked whether there were any suspected cases of ‘non-arteritic anterior is…
Criticism has emerged that the Ministry of Food and Drug Safety engaged in "delayed administration" by failing to conduct follow-up investigations, despite domestic reports that the administration of glucagon-like peptide (GLP-1) class obesity drugs could cause permanent vision loss. On the 13th, during the parliamentary audit held at the National Assembly, Minister Oh Yu-kyung...
(Seoul = Yonhap News) Reporter Shin Seon-mi = Suspected cases of vision loss following the administration of glucagon-like peptide-1 (GLP-1) class obesity and diabetes treatments overseas...
It has been reported that suspected cases of vision impairment have occurred in Korea as well, following the administration of glucagon-like peptide-1 (GLP-1) class obesity and diabetes treatments.
Coverage Details
Bias Distribution
- 67% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
